Prostate Cancer - Results from #26700

Surgical therapy for intermediate risk prostate cancer - Abstract December 8, 2011

Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: The essential importance of percentage of positive cores - Abstract December 8, 2011

ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer - Abstract December 8, 2011

Quality of life after hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer - Abstract December 8, 2011

Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the physicians' health study - Abstract December 8, 2011

Expansion/de-expansion tool to quantify the accuracy of prostate contours - Abstract December 8, 2011

Identification of markers of prostate cancer progression using candidate gene expression - Abstract December 7, 2011

General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations - Abstract December 7, 2011

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies - Abstract December 7, 2011

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer - Abstract December 7, 2011

Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer - Abstract December 7, 2011

Androgen deprivation and thromboembolic events in men with prostate cancer - Abstract December 6, 2011

Docetaxel-based chemotherapy for hormone-refractory prostate cancer in Japanese patients : Experience in a single institute - Abstract December 6, 2011

Bone mineral density, pathological fractures and bisphosphonate therapy in prostate cancer patients on androgen deprivation therapy - Abstract December 6, 2011

Lycopene for the prevention of prostate cancer - Abstract December 5, 2011

Whole-gland salvage high-intensity focused ultrasound therapy for localized prostate cancer recurrence after external beam radiation therapy - Abstract December 5, 2011

Active surveillance criteria for prostate cancer: Can they be applied to Japanese patients? - Abstract December 5, 2011

Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue - Abstract December 5, 2011

Low serum testosterone levels are predictive of prostate cancer - Abstract December 2, 2011

Parameters predicting postoperative unilateral disease in patients with unilateral prostate cancer in diagnostic biopsy: A rationale for selecting hemiablative focal therapy candidates - Abstract December 2, 2011

Page 1336 of 1437